DUSP family proteins, known for their regulatory roles in various disease contexts, such as chronic infections, autoimmune diseases, cancers, and age-related disorders, may hold promise as a druggable target over existing therapies that primarily work by manipulating protein kinase activity (An et al., 2021). Here, WEE1 is linked to autoimmune disease.